BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17163187)

  • 1. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection].
    Pedersen C; Kolmos HJ; Nielsen JO
    Ugeskr Laeger; 1997 Feb; 159(9):1233-8. PubMed ID: 9072866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in Europe: a problem of drug resistance or much more?
    Carvalho AC; Migliori GB; Cirillo DM
    Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in Poland, Europe, and world. Part I--prevalence].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):243-52. PubMed ID: 17163186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
    De Cock KM; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis, a re-emergent disease.
    Valadas E; Antunes F
    Eur J Radiol; 2005 Aug; 55(2):154-7. PubMed ID: 15905058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global aspects of tuberculosis in children.
    Datta M; Swaminathan S
    Paediatr Respir Rev; 2001 Jun; 2(2):91-6. PubMed ID: 12531054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tuberculosis in Europe and Poland--new molecular families and new resistance patterns].
    Augustynowicz-Kopeć E; Zwolska Z
    Przegl Epidemiol; 2008; 62(1):113-21. PubMed ID: 18536233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Global situation of TB and its control].
    Shimao T
    Kekkaku; 1999 Feb; 74(2):83-90. PubMed ID: 10191600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
    Corbett EL; Watt CJ; Walker N; Maher D; Williams BG; Raviglione MC; Dye C
    Arch Intern Med; 2003 May; 163(9):1009-21. PubMed ID: 12742798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis control in India--past, present and future.
    Prabhakar R
    J Indian Med Assoc; 2000 Mar; 98(3):123-5. PubMed ID: 11016168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TB pandemic: an old problem seeking new solutions.
    Meya DB; McAdam KP
    J Intern Med; 2007 Apr; 261(4):309-29. PubMed ID: 17391107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.